GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 65 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 54 | |
P/E GROWTH RATING 1..100 | 21 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EAFG | GSK | |
---|---|---|
RSI ODDS (%) | 2 days ago58% | 2 days ago51% |
Stochastic ODDS (%) | 2 days ago77% | 2 days ago47% |
Momentum ODDS (%) | 2 days ago75% | 2 days ago50% |
MACD ODDS (%) | 2 days ago80% | 2 days ago48% |
TrendWeek ODDS (%) | 2 days ago78% | 2 days ago51% |
TrendMonth ODDS (%) | 2 days ago68% | 2 days ago46% |
Advances ODDS (%) | 9 days ago79% | 5 days ago59% |
Declines ODDS (%) | N/A | 2 days ago52% |
BollingerBands ODDS (%) | 2 days ago86% | 2 days ago60% |
Aroon ODDS (%) | 2 days ago69% | 2 days ago45% |
A.I.dvisor tells us that EAFG and ROG have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAFG and ROG's prices will move in lockstep.
Ticker / NAME | Correlation To EAFG | 1D Price Change % | ||
---|---|---|---|---|
EAFG | 100% | N/A | ||
ROG - EAFG | 21% Poorly correlated | -0.98% | ||
GSK - EAFG | 20% Poorly correlated | -1.64% | ||
EVO - EAFG | 18% Poorly correlated | -4.07% | ||
AZN - EAFG | 15% Poorly correlated | -2.43% | ||
RIO - EAFG | 14% Poorly correlated | +2.44% | ||
More |
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.